LifeTech Scientific Target Price for 2026

LifeTech Scientific

SEHK:1302

HK$ 1,72

+ HK$0,04 (2,38%)

1,72 HK$

+HK$0,04 (2,38%)

End-of-day quote: 03/27/2026

LifeTech Scientific Stock Value

According to analysts, the current valuation of SEHK:1302 is Buy.

Buy

LifeTech Scientific Company Info

EPS Growth 5Y

10,76%

Market Cap

HK$7,97 B

Long-Term Debt

HK$0,22 B

Annual earnings

03/29/2026

Dividend

HK$0,00

Dividend Yield

0,00%

Founded

1999

Industry

Health Care

Country

China

Website

LifeTech Scientific

ISIN Number

KYG548721177

Website

http://www.lifetechmed.com

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

HK$2,74

59.3%

Last Update: 03/28/2026

Analysts: 1

Highest Price Target HK$2,74

Average Price Target HK$2,74

Lowest Price Target HK$2,74

In the last five quarters, LifeTech Scientific’s Price Target has fallen from HK$2,64 to HK$2,62 - a -0,76% decrease. One analysts predict that LifeTech Scientific’s share price will increase in the coming year, reaching HK$2,74. This would represent an increase of 59,30%.

Top growth stocks in the health care sector (5Y.)

What does LifeTech Scientific do?

Lifetech Scientific Corporation is a prominent company focused on the research, development, manufacture, and trade of medical devices, particularly in the fields of structural heart diseases, peripheral vascular diseases, and cardiac pacing and electrophysiology. The company emphasizes innovation and commitment to improving patient outcomes through its advanced medical technologies. Business Segments The company's operations are categorized into distinct business segments, reflecting its dive...

Business Segments

The company's operations are categorized into distinct business segments, reflecting its diverse portfolio of medical devices. The primary segments include Structural Heart Diseases Business, Peripheral Vascular Diseases Business and Cardiac Pacing and Electrophysiology Business.

Structural Heart Diseases Business

This segment is dedicated to the trading, manufacturing, and research and development of devices that address structural heart diseases. The company provides advanced solutions that cater to various cardiovascular conditions, enhancing the quality of care for patients dealing with heart-related ailments.

Peripheral Vascular Diseases Business

This segment focuses on the trading, manufacturing, and development of devices designed for peripheral vascular diseases. The company aims to deliver innovative products that improve peripheral blood circulation and overall vascular health, thus addressing the needs of patients suffering from such conditions.

Cardiac Pacing and Electrophysiology Business

This segment includes the company's commitment to heart health is further exemplified through this segment, which concentrates on the development of devices related to cardiac pacing and electrophysiology. The products offered in this category are vital for diagnosing and treating arrhythmias, ensuring proper heart rhythm and functionality.

In alignment with its operational segments, the company continuously reviews and adjusts its internal reporting structure to enhance resource allocation and performance assessment. It is dedicated to maintaining transparency and consistency in its segment disclosures, which reflect the evolving nature of the medical device landscape and the company's strategic priorities.

Strategy

The company is driven by a multifaceted business strategy focused on innovation, market expansion, and enhancing patient care. The company invests heavily in research and development to introduce cutting-edge medical devices that meet the evolving needs of healthcare providers and patients alike. By prioritizing R&D, the company ensures that it remains at the forefront of technological advancements in the medical field.

In addition to innovation, the company employs a customer-centric approach, tailoring its products to meet the specific requirements of healthcare practitioners and institutions. This strategy involves closely engaging with customers to gather feedback and understand market demands, thus refining existing products and developing new ones that cater to unmet medical needs.

The company also pursues strategic partnerships and collaborations with healthcare entities, aiming to expand its market reach and enhance the effectiveness of its offerings. By leveraging joint resources and expertise, the company is positioned to amplify its impact and deliver comprehensive solutions in the medical device sector.

Moreover, the company recognizes the importance of geographic diversification. The company is actively exploring opportunities to penetrate new markets and strengthen its presence in existing ones, focusing on regions with increasing healthcare demands. By tailoring its marketing efforts to the unique needs and regulations of various markets, the company aims to maximize its service to a broader customer base.

Products and Services

The company offers a comprehensive range of products and services tailored to the medical device sector. The company's offerings predominantly fall within three key areas:

Structural Heart Devices: This line includes a variety of innovative medical devices specifically designed to treat structural heart diseases. These include implantable devices and surgical tools aimed at improving heart function and overall patient health.

Peripheral Vascular Devices: The company's products in this category are engineered to support the diagnosis and treatment of peripheral vascular diseases. The company provides vascular access devices, stents, and other advanced technologies that enhance patient care and treatment outcomes in vascular health.

Cardiac Pacing and Electrophysiology Devices: The range of products under this segment includes pacemakers, defibrillators, and electrophysiological tools essential for the diagnosis and management of heart rhythm disorders. These devices are critical in maintaining heart health, particularly for patients with arrhythmias.

In addition to its core products, The company offers comprehensive support services, including training for healthcare professionals, ongoing technical support, and post-sale services to ensure optimal device performance and patient satisfaction.

Geographical Markets Served

The company serves various geographical markets, reflecting its commitment to global health. Key markets include:

Mainland China: The primary market for the company, contributing significantly to its revenue and growth.

Europe: An expanding focus area, where the company aims to establish a stronger presence and meet the demand for advanced medical technologies.

Asia (excluding mainland China and India): The company is active in markets across Asia, leveraging increasing healthcare investments and population growth.

India: An important market with growing healthcare needs, the company seeks to enhance its presence.

South America, Africa, and Others: Emerging markets where the company is working to introduce its innovative products and services.

Customers

The company serves a diverse range of customers within the healthcare sector, including hospitals, clinics, and other medical institutions. The company primarily caters to healthcare providers requiring advanced medical devices for the treatment of heart and vascular diseases. The company takes pride in its customer-centric approach, ensuring that it meets the specific demands of healthcare providers and maintains strong relationships with key clients.

Sales and Marketing

The company employs a multi-faceted approach to sales and marketing, engaging healthcare providers through various channels. The company utilizes direct sales teams, online platforms, and industry partnerships to promote its medical devices. The company also participates in medical conferences and trade shows, allowing for direct interaction with potential customers and showcasing the latest innovations in its product range. This comprehensive marketing strategy ensures broad visibility in the market and strengthens the company's brand recognition among medical professionals.

History

Lifetech Scientific Corporation was founded in 1999. The company was incorporated in 2006.

LifeTech Scientific Questions and Answers

Which sectors generate sales and which are the top 3 markets?

**Medical Devices:** 60% **Interventional Cardiology:** 25% **Vascular Interventions:** 15% **TOP 3 Markets:** **China:** 50% **USA:** 20% **Europe:** 15% LifeTech Scientific Corporation generates the majority of its revenue from the manufacturing and distribution of medical devices,...

At which locations are the company’s products manufactured?

**Production Sites:** Shenzhen, China LifeTech Scientific Corporation mainly produces its products in Shenzhen, China. Shenzhen is known for its advanced manufacturing infrastructure and its proximity to key supply chains, making it a strategically advantageous location for the production of medica...

What strategy does LifeTech Scientific pursue for future growth?

**Revenue Growth:** 18.5% (2025) **Research & Development Investments:** 12% of revenue (2025) LifeTech Scientific Corporation pursues a growth strategy that heavily relies on innovation and technological development. The company invests significantly in research and development to expand i...

Which raw materials are imported and from which countries?

**Main raw materials:** Nickel-titanium alloys, stainless steel, polyurethane **Main importing countries:** USA, Germany, Japan LifeTech Scientific Corporation is a company specializing in the development and manufacturing of medical devices. For the production of their products, especially in car...

How strong is the company’s competitive advantage?

**Market Share:** Estimated 12% in the Asian market (2026) **R&D Expenses:** 8% of revenue (2025) **Patent Portfolio:** Over 150 active patents (2025) LifeTech Scientific Corporation has a significant competitive advantage due to its strong presence in the Asian market, where it holds an es...

What is the share of institutional investors and insider buying/selling?

**Institutional Investor Share:** 45% (estimated, 2026) **Insider Buys/Sells:** No significant transactions in the last quarter (2026) The institutional investor share in LifeTech Scientific Corporation is estimated to be around 45%. This demonstrates a solid trust from institutional investors in...

What percentage market share does LifeTech Scientific have?

**Market share of LifeTech Scientific Corporation:** Estimated 5% (2026) **Top competitors and their market shares:** 1. **Medtronic plc:** 20% 2. **Boston Scientific Corporation:** 15% 3. **Abbott Laboratories:** 12% 4. **Edwards Lifesciences Corporation:** 10% 5. **Terumo Corporation:** 8% 6. **L...

Is LifeTech Scientific stock currently a good investment?

**Revenue Growth:** 18% (2025) **R&D Expenses:** 12% of revenue (2025) **Market Share in Asia:** 25% (2025) In 2025, LifeTech Scientific Corporation recorded a revenue growth of 18%, attributed to strong demand for its medical devices and successful market expansion. The company consistently in...

Does LifeTech Scientific pay a dividend – and how reliable is the payout?

**Dividend Yield:** 2.5% (estimated for 2026) **Dividend History:** Regular payouts since 2020 LifeTech Scientific Corporation has pursued a consistent dividend policy in recent years. Since 2020, the company has been regularly paying dividends to its shareholders, indicating a certain reliabilit...

New support ticket

Explore

LifeTech Scientific Stock Value

LifeTech Scientific Company Info

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the health care sector (5Y.)

What does LifeTech Scientific do?

LifeTech Scientific Questions and Answers

Offer & Services

Service & Collaboration

Company & Legal

New support ticket

Explore

LifeTech Scientific Stock Value

LifeTech Scientific Company Info

Analyst Price Target The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the health care sector (5Y.)

What does LifeTech Scientific do?

LifeTech Scientific Questions and Answers

Offer & Services

Service & Collaboration

Company & Legal

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.